TerrAscend Corp Asset Resilience Ratio
TerrAscend Corp asset resilience ratio. TerrAscend Corp (TED) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read TED liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of TerrAscend Corp (2018–2025)
Asset resilience ratio of TerrAscend Corp from 2018 to 2025. This chart shows how TerrAscend Corp's Asset Resilience Ratio has changed over time. See cash generation quality of TerrAscend Corp to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down TerrAscend Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see TED asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €362.00K | 0.06% |
| Total Liquid Assets | €362.00K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: TerrAscend Corp maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
TerrAscend Corp Industry Peers by Asset Resilience Ratio
Compare TerrAscend Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
Drug Manufacturers - Specialty & Generic | 5.90% |
|
Zhejiang Medicine Co Ltd
SHG:600216 |
Drug Manufacturers - Specialty & Generic | 1.85% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.09% |
|
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907 |
Drug Manufacturers - Specialty & Generic | 14.54% |
TerrAscend Corp Asset Resilience Ratio by Year (2018–2025)
TerrAscend Corp asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for TerrAscend Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.06% | €362.00K ≈ $423.22K |
€557.38 Million ≈ $651.63 Million |
-0.22pp |
| 2024-12-31 | 0.28% | €1.73 Million ≈ $2.02 Million |
€607.23 Million ≈ $709.92 Million |
0.00pp |
| 2023-12-31 | 0.29% | €1.91 Million ≈ $2.24 Million |
€666.52 Million ≈ $779.23 Million |
-0.23pp |
| 2022-12-31 | 0.51% | €3.60 Million ≈ $4.20 Million |
€701.59 Million ≈ $820.23 Million |
-- |
| 2021-12-31 | 0.00% | €0.00 ≈ $0.00 |
€581.93 Million ≈ $680.34 Million |
-- |
| 2019-12-31 | 0.10% | €465.00K ≈ $543.63K |
€460.77 Million ≈ $538.68 Million |
-8.54pp |
| 2018-12-31 | 8.64% | €7.69 Million ≈ $8.99 Million |
€88.98 Million ≈ $104.02 Million |
-- |
About TerrAscend Corp
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries und… Read more